Connection
Jose Castillo-Mancilla to Double-Blind Method
This is a "connection" page, showing publications Jose Castillo-Mancilla has written about Double-Blind Method.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.082 |
|
|
|
-
Rogg L, Nuñez SA, Mingrone MV, Domingo P, Rolle CP, Güerri-Fernandez R, Estrada V, Lopez M, Hanan N, Ghita GL, Jeffrey JL, Underwood M, Castillo-Mancilla JR, Halliday F, Ezeadi E, Gartland M. Proof-of-Concept Phase 2a Trial of VH4524184: An Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clin Infect Dis. 2026 Oct 28; 83(4):e819-e825.
Score: 0.043
-
Rogg L, Underwood M, Hanan N, Castillo-Mancilla JR, Kahl L, Halliday F, Ghita GL, Jeffrey JL, Byrne S, Onodera T, Horton J, Gartland M. Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clin Infect Dis. 2025 Oct 06; 81(3):510-520.
Score: 0.040
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|